Montmorillonite

DB13654InvestigationalSmall molecule

Montmorillonite is a purified clay indicated in the treatment of intestinal pain and diarrhea. A medication used to treat diarrhea and pain in the intestines.

Mechanism: Pharmacologically active on Pepsin A-5
Curator reviewed
Formula / weight: Al₂H₂O₁₂Si₄ · 360.307 g/mol (avg)
Also known as: Diosmectite · Montmorrillonite · Smectite

Resolves to

Compound

UNIIA585MN1H2LCAS1318-93-0

Clinical / RWD

RxNorm1425919ATCA07BC05

Structure

InChIKeyGUJOJGAPFQRJSV-UHFFFAOYSA-NSMILESO.[O--].[O--].[O--].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O

Targets

P0DJD9PGA5P08246ELANEP0DTC2S

What you can answer from here — as of July 07, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

29Drug interactionsStructured to mechanism, not free text

14Clinical trialsPhase, status and sponsor resolved per trial

2Structured indicationsCondition, population, route and combination as fields, not prose

1ContraindicationEach with its own population and attribute set

52Marketed productsAcross 6 countries and 35 labellers

1ATC codeIncluding every combination product, plus 15 drug categories

5+ReferencesStructured and connected to the statements they support

Which drugs share a target with Montmorillonite, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account